๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Use of an optical biosensor to measure prostate-specific antigen in whole blood

โœ Scribed by Paul M. O'Neill; Janys E. Fletcher; Christopher G. Stafford; Phelim B. Daniels; Tito Bacarese-Hamilton


Book ID
103961121
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
399 KB
Volume
29
Category
Article
ISSN
0925-4005

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Prostate specific antigen predominantly
โœ Hans Lilja; Abraham T. K. Cockett; Per-Anders Abrahamsson ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 471 KB ๐Ÿ‘ 2 views

Background. Prostate specific antigen (PSA) is a zymogen of a 33-kilodalton (kD) serine proteinase with extensive similarity to glandular kallikreins. The mechanism responsible for converting the zymogen into active proteinase has not been defined, but active PSA may be irreversibly inactivated in v

The use of prostate specific antigen den
โœ Paul R. Bretton; William P. Evans; James D. Borden; Ronald D. Castellanos ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 442 KB ๐Ÿ‘ 2 views

Background. Prostate specific antigen (PSA) is useful as a tumor marker for monitoring patients with prostate cancer after definitive therapy. Limitations have been noted when PSA was used for the early detection of prostate cancer. The use of prostate specific antigen density [PSAD = PSA (ng/ml)/pr